| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 15.21T | 9.66T | 8.77T | 5.78T | 3.80T | 3.57T |
| Gross Profit | 8.04T | 4.72T | 4.16T | 3.51T | 3.15T | 2.69T |
| EBITDA | 3.26T | 1.98T | 1.64T | 1.37T | 1.17T | 899.42B |
| Net Income | 2.37T | 1.18T | 962.95B | 805.84B | 706.63B | 512.81B |
Balance Sheet | ||||||
| Total Assets | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Cash, Cash Equivalents and Short-Term Investments | 69.26T | 10.00T> | 10.00T> | 75.91T | 74.79T | 10.00T> |
| Total Debt | 60.93T | 58.30T | 34.26T | 46.16T | 32.12T | 30.36T |
| Total Liabilities | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> | 10.00T> |
| Stockholders Equity | 15.65T | 14.70T | 14.66T | 12.68T | 12.10T | 11.83T |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.60T | 250.98B | -6.19T | 1.26T | 18.47T |
| Operating Cash Flow | 0.00 | 4.97T | 642.86B | -5.90T | 1.55T | 18.80T |
| Investing Cash Flow | 0.00 | -4.51T | -918.90B | 5.93T | -2.41T | -7.68T |
| Financing Cash Flow | 0.00 | -480.15B | 280.69B | -357.78B | -485.34B | -562.58B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $140.11B | 2.09 | 9.58% | 2.54% | 1.43% | 14.15% | |
73 Outperform | $306.91B | 9.62 | 12.07% | 4.14% | -6.12% | 12.49% | |
72 Outperform | $175.71B | 6.78 | 15.73% | 1.85% | -14.46% | 36.76% | |
69 Neutral | $204.63B | 13.57 | 9.31% | 2.48% | -0.93% | 3.71% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | $216.83B | 8.51 | 7.53% | 1.94% | 3.02% | 27.74% | |
65 Neutral | $230.07B | 11.96 | 12.04% | 1.80% | 1.28% | 16.35% |